Zobrazeno 1 - 10
of 44
pro vyhledávání: '"T, Gramage Caro"'
Autor:
Á Díaz Gago, Má Rodríguez Sagrado, MA Parro Martin, B Montero Llorente, A. Álvarez Díaz, M. Vélez Díaz-Pallares, T Gramage Caro
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance The current COVID-19 pandemic has resulted in the need to bring medications closer to patients treated in the outpatient units (OPU), and with it pharmaceutical telecare (PT) to avoid patients visiting the hospital. Aim and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70888b8ba2b4bcbbaaf7e0911057ce50
https://doi.org/10.1136/ejhpharm-2021-eahpconf.325
https://doi.org/10.1136/ejhpharm-2021-eahpconf.325
Autor:
V Calonge Jimenez, V Villena Valle, J Muñoz Olea, B Montero Llorente, A Miranda Del Cerro, T. Bermejo Vicedo, B Bravo Jiménez, E. Delgado Silveira, T Gramage Caro, R Pacheco Garrido, M. Vélez-Díaz-Pallarés
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance The population with HIV is increasingly ageing. This premature ageing is estimated at 10 years. The consequence is that these patients suffer polymedication and more comorbidities than non-infected populations at earlier sta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae48f3685e7520244725f9db220d0c5d
https://doi.org/10.1136/ejhpharm-2020-eahpconf.353
https://doi.org/10.1136/ejhpharm-2020-eahpconf.353
Autor:
MT Bermejo Vicedo, Má Rodríguez Sagrado, L Quesada-Muñoz, M Rodríguez Marín, M. Vélez-Díaz-Pallarés, N Vicente Oliveros, S Sanz Merino, B Montero Llorente, T Gramage Caro
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Recently, change from cobicistat to ritonavir is being promoted at a tertiary hospital for economic reasons. Therefore, there is a growing need to study what this switch may involve. Aim and objectives Our objective was to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::041fd0b37106343365c184f4323bed28
https://doi.org/10.1136/ejhpharm-2020-eahpconf.167
https://doi.org/10.1136/ejhpharm-2020-eahpconf.167
Autor:
Má Rodríguez Sagrado, T. Bermejo Vicedo, B Montero Llorente, M. Vélez-Díaz-Pallarés, B Esteban Cartelle, T Gramage Caro
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance The main problem of antiretroviral therapy (ART) that includes pharmacokinetic enhancers (cobicistat or ritonavir) is inhibition of the metabolism of numerous drugs, which can lead to adverse drug reactions (ADR) due to over
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bd87458c1d1857973fafb25c0e70e55
https://doi.org/10.1136/ejhpharm-2020-eahpconf.347
https://doi.org/10.1136/ejhpharm-2020-eahpconf.347
Autor:
M. Vélez-Díaz-Pallarés, N Vicente Oliveros, MJ Vivancos Gallego, A Moreno Zamora, T Gramage Caro, Má Rodríguez Sagrado, M Salgado Del Valle, T. Bermejo Vicedo, B Montero Llorente, Z Santander Sánchez
Publikováno v:
Section 6: Education and Research.
Background Tenofovir alafenamide (TAF) is associated with less renal and bone toxicity compared with tenofovir disoproxil (TDF) but with elevation of cholesterol levels. In our hospital, patients were automatically changed from a regimen with Evipler
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afd8e66e50bce0b15dd22ab1cff72cd4
https://doi.org/10.1136/ejhpharm-2019-eahpconf.606
https://doi.org/10.1136/ejhpharm-2019-eahpconf.606
Autor:
M Carreter Garnica, C Palomar Fernández, MJ Vivancos Gallego, M. Vélez-Díaz-Pallarés, A Moreno Zamora, T. Bermejo Vicedo, E Ilies, T Gramage Caro, M Atienza Martín, Má Rodríguez Sagrado
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Cobicistat is used in clinical practice as a pharmacokinetic enhancer of protease and/or integrase inhibitors. Nevertheless, the mechanism by which this occurs (metabolism inhibition) makes cobicistat-containing HIV regimens very prone to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::149ff410a8e7183f0728f456b2bab248
https://doi.org/10.1136/ejhpharm-2019-eahpconf.246
https://doi.org/10.1136/ejhpharm-2019-eahpconf.246
Autor:
T Gramage Caro, N Vicente Oliveros, C. Pérez Menéndez-Conde, T. Bermejo Vicedo, E. Delgado Silveira, AMAlvarez Díaz
Publikováno v:
Patient safety and risk management.
Background New technology can improve patient safety but also has the potential to introduce new errors and risks into healthcare delivery Purpose To evaluate the effect of an electronic medication administration record (eMAR) application on the rate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d34cf2f04c2c3b6119e7ed29a63b40e
https://doi.org/10.1136/ejhpharm-2017-000640.580
https://doi.org/10.1136/ejhpharm-2017-000640.580
Autor:
M. Vélez-Díaz-Pallarés, MA Rodríguez Sagrado, T. Bermejo Vicedo, T Gramage Caro, I Taladriz Sender
Publikováno v:
Drug information and pharmacotherapy.
Background The Treatment Satisfaction Questionnaire for Medication (TSQM) was designed to assess patient treatment satisfaction in chronic diseases. Its performance can be used in multiple sclerosis (MS). Purpose To compare treatment satisfaction in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a46718a348053843798e0140accb0947
https://doi.org/10.1136/ejhpharm-2017-000640.332
https://doi.org/10.1136/ejhpharm-2017-000640.332
Autor:
M.E. Gómez de Salazar López de Silanes, M. Sánchez Cuervo, C. Pueyo López, C Palomar Fernández, T Gramage Caro, T. Bermejo Vicedo
Publikováno v:
Farmacia Hospitalaria. 35:197-203
Method: Prospective study. A data sheet was designed based on ASHP’s classification. Two observers reviewed the treatment prescribed for chemotherapy from the Haematology Department during a month and they classified the errors detected. The intero
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f057ba2db91867783bc82803c2842bfe
https://doi.org/10.1016/j.farma.2010.04.006
https://doi.org/10.1016/j.farma.2010.04.006
Autor:
M.E. Gómez de Salazar López de Silanes, T. Bermejo Vicedo, M. Sánchez Cuervo, C. Pueyo López, C Palomar Fernández, T Gramage Caro
Publikováno v:
Farmacia Hospitalaria (English Edition). 35:197-203
Objective To validate a classification sheet for medication errors associated with antineoplastic medication. Method Prospective study. A data sheet was designed based on ASHP's classification. Two observers reviewed the treatment prescribed for chem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::846261fb15c1ee216f765713df1d222b
https://doi.org/10.1016/j.farmae.2010.04.001
https://doi.org/10.1016/j.farmae.2010.04.001